Vasodilator therapy of dilated cardiomyopathy.

Vasodilator therapy of dilated cardiomyopathy.

Vasoconstriction increases impedance to ventricular ejection and impairs the performance of the dilated myopathic heart. Vasodilator drug therapy by reducing vascular resistance, increasing vascular compliance and increasing vascular capacitance improves cardiac function and relieves the signs and symptoms of congestive heart failure. Earlier intervention in an attempt to alter the natural hist...

[Cell therapy in dilated cardiomyopathy].

A forty-one-year-old male with systolic heart failure, FC-III NYHA, clinical stage C due to dilated cardiomyopathy was submitted to an autologous transplant of the mononuclear fraction of bone marrow via coronary artery system through heart catheterism. Two months after the procedure, there was a decrease in plasma BNP and cardiac area reduction at the thorax X-ray and nuclear magnetic resonanc...

Drug Therapy in Dilated Cardiomyopathy and Myocarditis

The book Drug Therapy in Dilated Cardiomyopathy and Myocarditis is one of 11 volumes in a series of monographs on basic and clinical cardiology. It deals with the traditional, novel, and experimental pharmacologic agents used to treat congestive heart failure (CHF) and myocarditis, and with the relationship between these two disorders. The precise definition of dilated cardiomyopathy differs ac...

Dilated Cardiomyopathy

Dilated cardiomyopathy.